• Advances in the Understanding of Etiology (I)
• 30 min
  1. Infection and autoimmunity: a two-way relationship

  • Dr. Ricard Cervera
• 35 min
  2. Autoimmunity and atherosclerosis

  • Prof. Johan Frostegard
• 47 min
  3. Endothelium and autoimmunity

  • Prof. Pier Luigi Meroni
• Advances in the Understanding of Etiology (II)
• 22 min
  4. Prolactin has a pathogenic role in systemic lupus erythematosus

  • Prof. Luis Jara-Quezada
• 44 min
  5. Sjögren's syndrome: current knowledge and future prospects

  • Prof. Athanasios G. Tzioufas
• 51 min
  6. Genetic and environmental triggers of autoimmune thyroid diseases

  • Prof. Yaron Tomer
• Advances in Pathogenesis and Clinical Manifestation
• 38 min
  7. The catastrophic antiphospholipid syndrome and the microangiopathic antiphospholipid syndrome

  • Prof. Ronald Asherson
• 20 min
  8. Pathogenic mechanisms of autoantibodies: circulating and local antibodies that form immune complexes

  • Dr. Luís Eduardo Coelho Andrade
• 34 min
  9. Pathogenic mechanisms of autoantibodies: antibodies to intracellular and membrane-bound antigens

  • Dr. Luís Eduardo Coelho Andrade
• 43 min
  10. What causes primary biliary cholangitis?

  • Dr. M. Eric Gershwin
• 30 min
  11. Capillaroscopy in autoimmune rheumatic diseases

  • Prof. Maurizio Cutolo
• Advances in Diagnostic Methodologies (I)
• 26 min
  12. The past, present & future of ANA testing: history and challenges of ANA

  • Prof. Marvin J. Fritzler
• 33 min
  13. The past, present & future of ANA testing: changing bandwidth and future of ANA

  • Prof. Marvin J. Fritzler
• 36 min
  14. Diagnostic methods in autoimmunity

  • Mr. Steven Binder
• 24 min
  15. Systemic lupus erythematosus: novel aspects of pathogenesis and treatment 1

  • Prof. Chaim Putterman
  • Dr. Noa Schwartz
• 28 min
  16. Systemic lupus erythematosus: novel aspects of pathogenesis and treatment 2

  • Prof. Chaim Putterman
  • Dr. Noa Schwartz
• 48 min
  17. Novel aspects of systemic sclerosis

  • Prof. Gabriele Valentini
• Advances in Diagnostic Methodologies (II)
• 46 min
  18. An update on the multiple faces of celiac disease

  • Prof. Aaron Lerner
• 23 min
  19. Protective autoantibodies

  • Prof. Elias Toubi
• 32 min
  20. CD44 genetic deletion enhances and CD44 antibody targeting attenuates autoimmune inflammation

  • Prof. David Naor
• 44 min
  21. Rheumatic fever: a model of a post-infectious autoimmune disease

  • Prof. Jorge Kalil
• Treatments of autoimmune diseases
• 38 min
  22. Intravenous immunoglobulins: clinical evidence

  • Prof. Shaye Kivity
• Latest Developments in the Field
• 26 min
  23. Adjuvants and autoimmunity

  • Dr. Eitan Israeli
• 46 min
  24. Antiphospholipid syndrome (APS): from pathogenesis to treatment

  • Prof. Roger Levy
• 24 min
  25. Vitamin D and autoimmunity

  • Dr. Shir Azrielant
• 28 min
  26. Pregnancy in rheumatic diseases

  • Prof. Pier Luigi Meroni
• Archived Lectures *These may not cover the latest advances in the field
• 47 min
  27. Pathogenic mechanisms of autoantibodies

  • Prof. Cees Kallenberg
• 41 min
  28. B lymphocytes on the frontline of autoimmunity

  • Prof. Pierre Youinou
• 42 min
  29. Apoptotic cell clearance deficiency

  • Prof. Martin Herrmann
• 34 min
  30. Auto-antibodies as predictors of autoimmune disease

  • Dr. Nicola Bizzaro
• 46 min
  31. Innate immunity and natural autoantibodies

  • Prof. Luc Mouthon
• 45 min
  32. Accelerated atherosclerosis in autoimmune rheumatic disease

  • Dr. Andrea Doria
• 47 min
  33. Pregnancy in autoimmune rheumatic diseases

  • Prof. Angela Tincani
• 42 min
  34. Pulmonary hypertension in the connective tissue disease pathogenesis, clinical features and therapeutic options in 2006

  • Prof. Ronald Asherson
• 39 min
  35. Use of algorithms for high quality diagnostics and handling of patients with autoimmune rheumatic diseases

  • Dr. Allan Wiik
• 24 min
  36. Immunologic mechanisms in systemic lupus erythematosus

  • Prof. Kok-Yong Fong
• 23 min
  37. Osteoimmunology

  • Prof. João Eurico Fonseca
  • Ms. Joana Caetano-Lopes
• 43 min
  38. ANCA-associated systemic vasculitides

  • Prof. Loic Guillevin
• 23 min
  39. The common origin for diverse autoimmune diseases

  • Prof. Juan-Manuel Anaya
• 76 min
  40. Anti-cytokine therapy in rheumatoid arthritis

  • Prof. Piercarlo Sarzi-Puttini
• 40 min
  41. Sjogren's syndrome: autoimmune epithelitis

  • Prof. Haralampos Moutsopoulos
• 31 min
  42. Vitamin D and autoimmunity

  • Dr. Howard Amital
• 25 min
  43. Intravenous immunoglobulins: myth and reality

  • Prof. Zera Tellier

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. What is autoimmunity?
3. Female dominance in most autoimmune diseases
4. Concept of tolerance
5. Central tolerance
6. Peripheral tolerance (1)
7. Peripheral tolerance (2)
8. Breakdown of tolerance
9. What is needed for autoimmunity to occur?
10. Autoimmune diseases (1)
11. Autoimmune diseases (2)
12. Susceptibility to autoimmune diseases
13. Infection and initiation of autoimmunity (1)
14. Initiation by bacterial infection
15. Infection and initiation of autoimmunity (2)
16. Initiation by viruses
17. Infection and initiation of autoimmunity (3)
18. Examples of important autoimmune diseases (1)
19. Temporal arteritis
20. Examples of important autoimmune diseases (2)
21. Systemic lupus erythematosus (SLE)
22. Risk of cardiovascular disease (CVD) in SLE
23. Nested case control design
24. Risk factors of CVD in SLE
25. Examples of important autoimmune diseases (3)
26. Atherosclerosis
27. Atherosclerosis is an inflammatory disease
28. Pro-inflammatory cytokines in atherosclerosis
29. Plaque rupture leads to thrombosis
30. The immune system in atherosclerosis (1)
31. Heat shoch proteins
32. Heat shock proteins (HSP) and atherosclerosis
33. The immune system in atherosclerosis (2)
34. Modification of LDL
35. PAF and PAF-like lipids
36. Oxidized LDL
37. The immune system in atherosclerosis (3)
38. Phosphorylcholine: epitope in OxLDL
39. ELSA study design
40. Study results
41. Immunological differences between sexes
42. Potential mechanisms for protective effects of aPC
43. The immune system in atherosclerosis (4)
44. Anti-phospholipid (aPL) antibodies
45. Annexin A5
46. Role of annexin-A5 in SLE-related CVDs (1)
47. Role of annexin-A5 in SLE-related CVDs (2)
48. Effect of IVIG on annexin A5 binding (1)
49. Effect of IVIG on annexin A5 binding (2)
50. Monoclonal aPL Ab inhibits annexin A5 binding
51. How can aPL antibodies cause disease?
52. Lupus anticoagulants
53. Summary and conclusions
54. Acknowledments

Topics Covered

• Autoimmunity
• High risk of atherosclerosis in autoimmune diseases, especially systemic lupus erythematosus (SLE)
• Antiphospholipid antibodies and atherosclerosis
• Association and risk factors for atherosclerosis and cardiovascular disease in SLE
• Autoimmune mechanisms in atherosclerosis in general

Links

Series:

• Autoimmunity

Categories:

• Clinical Practice
• Immunology

Therapeutic Areas:

• Cardiovascular & Metabolic
• Immunology & Inflammation

Talk Citation

Publication History

• Published on October 1, 2007

Financial Disclosures

• Prof. Johan Frostegard has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.